Musculoskeletal Disorders Drugs Market Research Reports

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Report
  • 148 Pages
From
Epiomic Epidemiology Series: X-Linked Hypophosphataemia Forecast In 20 Major Markets 2018–2028 - Product Thumbnail Image

Epiomic Epidemiology Series: X-Linked Hypophosphataemia Forecast In 20 Major Markets 2018–2028

  • Report
  • 64 Pages
From
Drugs for Rheumatoid Arthritis: Global Markets to 2022 - Product Thumbnail Image

Drugs for Rheumatoid Arthritis: Global Markets to 2022

  • Report
  • 182 Pages
From
Global Musculoskeletal Partnering 2012-2018: Deal trends, players and financials - Product Thumbnail Image

Global Musculoskeletal Partnering 2012-2018: Deal trends, players and financials

  • Report
  • 1000 Pages
From
Stem Cell Therapy for Osteoarthritis - A Pipeline Analysis Report - Product Thumbnail Image

Stem Cell Therapy for Osteoarthritis - A Pipeline Analysis Report

  • Report
  • 70 Pages
From
Rheumatoid Arthritis Therapeutics Market Size Analysis Report By Molecule Type, By Sales Channel (Prescription, OTC), And Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics Market Size Analysis Report By Molecule Type, By Sales Channel (Prescription, OTC), And Segment Forecasts, 2018 - 2025

  • Report
  • 85 Pages
From
Musculoskeletal Diseases Market: By Type; By Treatment & By Region - Forecast 2016-2022 - Product Thumbnail Image

Musculoskeletal Diseases Market: By Type; By Treatment & By Region - Forecast 2016-2022

  • Report
  • 147 Pages
From
Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Report
  • 140 Pages
From
Ankylosing Spondylitis Forecast in 13 Major Markets 2017-2027 - Product Thumbnail Image

Ankylosing Spondylitis Forecast in 13 Major Markets 2017-2027

  • Report
  • 70 Pages
From
Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026 - Product Thumbnail Image

Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

  • Report
  • 74 Pages
From
Muscular Dystrophies Forecast in 12 Major Markets 2017-2027 - Product Thumbnail Image

Muscular Dystrophies Forecast in 12 Major Markets 2017-2027

  • Report
  • 44 Pages
From
Osteoarthritis Forecast in 12 Major Markets 2016-2026 - Product Thumbnail Image

Osteoarthritis Forecast in 12 Major Markets 2016-2026

  • Report
  • 66 Pages
From
Osteopenia & Osteoporosis Forecast in 13 Major Markets 2017-2027 - Product Thumbnail Image

Osteopenia & Osteoporosis Forecast in 13 Major Markets 2017-2027

  • Report
  • 84 Pages
From
Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies - Product Thumbnail Image

Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies

  • Report
  • 131 Pages
From
Fibromyalgia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Fibromyalgia Therapeutics - Global Strategic Business Report

  • Report
  • 78 Pages
From
Lower Back Pain and Sciatica Forecast in 9 Major Markets 2016-2026 - Product Thumbnail Image

Lower Back Pain and Sciatica Forecast in 9 Major Markets 2016-2026

  • Report
  • 46 Pages
From
Enbrel Biosimilars Clinical Trial & Opportunity Insight - Product Thumbnail Image

Enbrel Biosimilars Clinical Trial & Opportunity Insight

  • Report
  • 70 Pages
From
Humira Biosimilars Clinical Trial Insight - Product Thumbnail Image

Humira Biosimilars Clinical Trial Insight

  • Clinical Trials
  • 80 Pages
From
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation - Product Thumbnail Image

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

  • Report
  • 66 Pages
From
Remicade (Infliximab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Remicade (Infliximab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • 50 Pages
From
Loading Indicator
adroll